Xeliri Plus Bevacizumab Compared with Folfiri Plus Bevacizumab as First-Line Setting in Patients with Metastatic Colorectal Cancer: Experiences at Two-Institutions
-
- Asian Pacific Journal of Cancer Prevention
- /
- v.14 no.4
- /
- pp.2283-2288
- /
- 2013